FVLKX | VEVYX | FVLKX / VEVYX | |
Total Expense Ratio | 0.73 | 0.66 | 111% |
Annual Report Gross Expense Ratio | 0.73 | 0.66 | 111% |
Fund Existence | 17 years | 12 years | - |
Gain YTD | -14.516 | -11.002 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.95B | 15.9B | 50% |
Annual Yield % from dividends | 1.13 | 1.12 | 101% |
Returns for 1 year | -23.50 | -16.23 | 145% |
Returns for 3 years | -17.87 | -13.46 | 133% |
Returns for 5 years | 93.58 | 65.51 | 143% |
Returns for 10 years | 4.97 | 30.31 | 16% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SLYV | 70.45 | -3.26 | -4.42% |
SPDR® S&P 600 Small Cap Value ETF | |||
OVS | 27.78 | -1.36 | -4.68% |
Overlay Shares Small Cap Equity ETF | |||
PPH | 83.89 | -5.00 | -5.62% |
VanEck Pharmaceutical ETF | |||
ENZL | 40.13 | -2.59 | -6.06% |
iShares MSCI New Zealand ETF | |||
FIVA | 24.35 | -1.69 | -6.49% |
Fidelity International Value Factor ETF |